SCHEMBL7984072

SCHEMBL7984072

O=CNc1cccc(-c2ncc[nH]2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VCP P55072 2/20 0.52
NISCH Q9Y2I1 2/20 0.50
MTOR P42345 1/20 0.50
ADK P55263 1/20 0.50
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 2/20 0.40
LIMK1 P53667 1/20 0.39
BRD4 O60885 1/20 0.38
CCR3 P51677 1/20 0.37
ADRB2 P07550 1/20 0.37
ADRB1 P08588 1/20 0.37
ADRB3 P13945 1/20 0.37
HCRTR1 O43613 1/20 0.36
MRGPRX4 Q96LA9 1/20 0.36
PDE3B Q13370 1/20 0.36
PDE3A Q14432 1/20 0.36
PARP1 P09874 1/20 0.35
MAPK14 Q16539 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24782866 0.80 NISCH (0.55) VCPNISCHMTORADKALDH1A1
SCHEMBL16777437 0.78 NISCH (0.72) VCPNISCHMTORADKALDH1A1
SCHEMBL23214195 0.78 VCP (0.67) VCPNISCHMTORADKALDH1A1
SCHEMBL29957239 0.76 NISCH (0.55) VCPNISCHMTORADKALDH1A1
SCHEMBL4623510 0.76 NISCH (0.55) VCPNISCHMTORADKALDH1A1
SCHEMBL13996504 0.76 NISCH (0.50) VCPNISCHMTORADKALDH1A1
SCHEMBL13994010 0.76 NISCH (0.50) VCPNISCHMTORADKALDH1A1
SCHEMBL28214132 0.74 ALDH1A1 (0.56) ALDH1A1LIMK1MEN1KMT2A
SCHEMBL7967769 0.74 VCP (0.56) VCPNISCHMTORADKALDH1A1
SCHEMBL12607523 0.73 NISCH (0.50) VCPNISCHMTORADKALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001087845-A2 N-CONTAINING HETEROCYCLIC COMPOUNDS AND THEIR USE AS 5-HT ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-22 WO disclosed